Increased expression of Lrp10 in human hepatocellular carcinoma, lung adenocarcinoma, and pancreatic adenocarcinoma is associated with decreased patient survival (Gonias et al, 2017). This evidence concerns the gene LRP10 and lung adenocarcinoma.